antineoplastics
455 results
242 - 341
vemurafenib- regorafenib
- vincristine liposome
- cobimetinib
- elotuzumab
- encorafenib
- alpelisib
- binimetinib
- dacomitinib
- polatuzumab vedotin
- isatuximab
- larotrectinib
- gilteritinib
- capivasertib
- elranatamab
- fruquintinib
- margetuximab
- talquetamab
- tebentafusp
- eflornithine (systemic)
- DOCEtaxel
- epiRUBicin
- fluorouracil
- hydroxyurea
- interferon alfacon-1
- irinotecan
- temozolomide
- methotrexate
- diethylstilbestrol
- lenalidomide
- lapatinib
- nilotinib
- carfilzomib
- obinutuzumab
- mechlorethamine (topical)
- afatinib
- necitumumab
- neratinib
- avelumab
- olaratumab
- moxetumumab pasudotox
- ivosidenib
- enfortumab vedotin
- DOXOrubicin hydrochloride
- brentuximab vedotin
- tretinoin (systemic)
- ruxolitinib (systemic)
- ripretinib
- altretamine
- CISplatin
- cycloPHOSphamide
- DAUNOrubicin hydrochloride
- goserelin
- ifosfamide
- pentamidine
- thioguanine
- PEMEtrexed
- methyl aminolevulinate
- everolimus
- pertuzumab
- blinatumomab
- nivolumab
- pembrolizumab
- ado-trastuzumab
- alectinib
- osimertinib
- trifluridine/tipiracil
- ramucirumab
- cemiplimab
- decitabine/cedazuridine
- infigratinib
- dostarlimab
- loncastuximab tesirine
- olutasidenib
- amifostine
- arsenic trioxide
- megestrol
- mercaptopurine
- DOXOrubicin, liposomal
- ipilimumab
- irinotecan liposomal
- durvalumab
- avapritinib
- erdafitinib
- pemigatinib
- tisotumab vedotin
- mobocertinib
- belzutifan
- futibatinib
- sirolimus (protein bound)
- tremelimumab
- PACLitaxel
- riTUXimab
- trastuzumab
- testosterone enanthate
- tositumomab (I 131 tositumomab)
- lycopene
- atezolizumab